Skip to Content
Merck
  • Direct Genetic and Enzymatic Evidence for Oxidative Cyclization in Hygromycin B Biosynthesis.

Direct Genetic and Enzymatic Evidence for Oxidative Cyclization in Hygromycin B Biosynthesis.

ACS chemical biology (2018-06-08)
Sicong Li, Jun Zhang, Yuanzhen Liu, Guo Sun, Zixin Deng, Yuhui Sun
ABSTRACT

Hygromycin B is an aminoglycoside antibiotic with a structurally distinctive orthoester linkage. Despite its long history of use in industry and in the laboratory, its biosynthesis remains poorly understood. We show here, by in-frame gene deletion in vivo and detailed enzyme characterization in vitro, that formation of the unique orthoester moiety is catalyzed by the α-ketoglutarate- and non-heme iron-dependent oxygenase HygX. In addition, we identify HygF as a glycosyltransferase adding UDP-hexose to 2-deoxystreptamine, HygM as a methyltransferase responsible for N-3 methylation, and HygK as an epimerase. These experimental results and bioinformatic analyses allow a detailed pathway for hygromycin B biosynthesis to be proposed, including the key oxidative cyclization reactions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Deoxystreptamine dihydrobromide, ≥97% (TLC)